Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding - PubMed (original) (raw)
. 1997 May 1;158(9):4237-44.
Affiliations
- PMID: 9126985
Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding
X Tao et al. J Immunol. 1997.
Abstract
The adaptive immune responses to foreign Ags are primarily regulated by the cytokines produced by CD4 T cells. The generation of distinct cytokine-producing T cell subsets has been shown to be influenced by a number of factors, including cytokines, different types of APCs, and the amounts of priming Ag. We have previously reported that the affinity of an antigenic peptide for its presenting MHC class II molecules and that different doses of Ag peptide affect the outcome of the functional CD4 T cell response. In the current study, we further examined the impact of the affinity of an antigenic peptide for its TCR on CD4 T cell priming. We generated a panel of Ag peptide variants mutated at positions known to be critical for binding to a well-characterized TCR (known as altered peptide ligands, or APLs). Compared with the WT peptide, these APLs are defective in stimulating the proliferative responses of T cells. However, they can effectively prime in vitro naive CD4 T cells for differentiation into both Th1-like and Th2-like cells. In contrast, the WT peptide primes only for IFN-gamma-producing Th1-like cells. Using highly purified dendritic cells as APCs to present the APL or WT peptide leads to the same pattern of priming as using total splenic APCs. These results indicate that priming by APLs for both IL-4 production and IFN-gamma production does not require two different types of APCs. In summary, our data indicate that APL can directly stimulate naive CD4 T cells to become Th2 effector cells.
Similar articles
- The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
Tamura T, Ariga H, Kinashi T, Uehara S, Kikuchi T, Nakada M, Tokunaga T, Xu W, Kariyone A, Saito T, Kitamura T, Maxwell G, Takaki S, Takatsu K. Tamura T, et al. Int Immunol. 2004 Dec;16(12):1691-9. doi: 10.1093/intimm/dxh170. Epub 2004 Oct 11. Int Immunol. 2004. PMID: 15477229 - Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.
Constant SL, Bottomly K. Constant SL, et al. Annu Rev Immunol. 1997;15:297-322. doi: 10.1146/annurev.immunol.15.1.297. Annu Rev Immunol. 1997. PMID: 9143690 Review. - Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
Nishimura Y, Chen YZ, Kanai T, Yokomizo H, Matsuoka T, Matsushita S. Nishimura Y, et al. Intern Med. 1998 Oct;37(10):804-17. doi: 10.2169/internalmedicine.37.804. Intern Med. 1998. PMID: 9840700 Review.
Cited by
- Understanding the development of Th2 cell-driven allergic airway disease in early life.
León B. León B. Front Allergy. 2023 Jan 10;3:1080153. doi: 10.3389/falgy.2022.1080153. eCollection 2022. Front Allergy. 2023. PMID: 36704753 Free PMC article. Review. - Immune Modulation by Antigenic Peptides and Antigenic Peptide Conjugates for Treatment of Multiple Sclerosis.
Mahadik R, Kiptoo P, Tolbert T, Siahaan TJ. Mahadik R, et al. Med Res Arch. 2022 May;10(5):10.18103/mra.v10i5.2804. doi: 10.18103/mra.v10i5.2804. Epub 2022 Jun 1. Med Res Arch. 2022. PMID: 36381196 Free PMC article. - Inborn Errors of the Immune System Associated With Atopy.
Nelson RW, Geha RS, McDonald DR. Nelson RW, et al. Front Immunol. 2022 Apr 27;13:860821. doi: 10.3389/fimmu.2022.860821. eCollection 2022. Front Immunol. 2022. PMID: 35572516 Free PMC article. Review. - IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.
Dwyer GK, Mathews LR, Villegas JA, Lucas A, Gonzalez de Peredo A, Blazar BR, Girard JP, Poholek AC, Luther SA, Shlomchik W, Turnquist HR. Dwyer GK, et al. J Clin Invest. 2022 Jun 15;132(12):e150927. doi: 10.1172/JCI150927. J Clin Invest. 2022. PMID: 35503257 Free PMC article. - Schnurri 3 promotes Th2 cytokine production during the late phase of T-cell antigen stimulation.
Cunha C, Koike T, Seki Y, Yamamoto M, Iwashima M. Cunha C, et al. Eur J Immunol. 2022 Jul;52(7):1077-1094. doi: 10.1002/eji.202149633. Epub 2022 May 11. Eur J Immunol. 2022. PMID: 35490426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous